Office of Dietary Supplements 2010-2014 Strategic Plan, 71016-71017 [E8-27791]

Download as PDF 71016 Federal Register / Vol. 73, No. 227 / Monday, November 24, 2008 / Notices The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group, NHLBI Institutional Training Mechanism Review Committee. Date: December 12, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Four Points by Sheraton/BWI, 7032 Elm Road, Baltimore, MD 21240. Contact Person: Charles Joyce, Ph.D., Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892–7924, 301–435– 0288, cjoyce@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: November 14, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–27796 Filed 11–21–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sroberts on PROD1PC70 with NOTICES National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Aug<31>2005 19:32 Nov 21, 2008 Jkt 217001 Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel. Date: December 3–4, 2008. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: The Tuscan Inn, 495 Jefferson Street, San Francisco, CA 94109. Contact Person: Phillip F. Wiethorn, Scientific Review Administrator, DHHS/NIH/ NINDS/DER/SRB, 6001 Executive Boulevard; Msc 9529, Neuroscience Center; Room 3203, Bethesda, MD 20892–9529, (301) 496–5388, wiethorp@ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel Reviewer Conflicts. Date: December 5, 2008. Time: 4 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Joann McConnell, PhD., Scientific Review Administrator, Scientific Review Branch, NIH/NINDS/Neuroscience Center, 6001 Executive Blvd., Suite 3208, Msc 9529, Bethesda, MD 20892–9529, (301) 496–5324, mcconnej@ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: November 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–27798 Filed 11–21–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Dietary Supplements 2010– 2014 Strategic Plan Notice of Opportunity for Public Comment and Public Meetings. ACTION: SUMMARY: The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) has initiated a strategic planning process that will culminate in the ODS Strategic Plan for 2010–2014. To assist with this process, the ODS requests input from research communities—academic, government, PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 and industry—and from other interested parties. The overall purpose of the strategic planning effort is to identify both new opportunities and emerging needs for incorporation in the programmatic efforts of the Office. A background paper has been prepared, A Report to the Public, that summarizes progress in four key areas of ODS activity. The background paper and related information are available on the ODS Web site at http://ods.od.nih.gov/ strategicplan. Public comment can be sent directly to ODS or through the public Webinars ODS will hold on January 29, 2009, February 3, 2009, February 11, 2009, and February 19, 2009. The section on Public Participation (below) gives details for the Webinars. DATES: In order to ensure full consideration, all responses must be submitted by midnight, March 31, 2009. ADDRESSES: Interested individuals and organizations should submit their responses to ODSplan@od.nih.gov. FOR FURTHER INFORMATION CONTACT: Julia B. Freeman, Ph.D., Office of Dietary Supplements, National Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892–7517, Phone: 301–496–0187, Fax: 301–480– 1845, E-mail: ODSplan@od.nih.gov. SUPPLEMENTARY INFORMATION: Background The mission of the Office of Dietary Supplements (ODS) is to strengthen knowledge and understanding of dietary supplements by evaluating scientific information, stimulating and supporting research, disseminating research results, and educating the public to foster an enhanced quality of life and health for the U.S. population. The ODS was established in the Office of the Director, NIH, in 1995 as a major provision of the Dietary Supplement Health and Education Act of 1994 (DSHEA). A key early activity was the development of the Strategic Plan for 1998–2003 to set out goals for program development. The Strategic Plan was prepared with considerable input from NIH Institutes and Centers, other Federal Agencies, consumers, and other interested parties. The original five-year plan was revised for 2004–2009. The five strategic goals for ODS have been: 1. Expand the evaluation of the role of dietary supplements in disease prevention and in reduction of risk factors associated with disease. 2. Foster research that evaluates the role of dietary supplements in maintaining and improving optimal E:\FR\FM\24NON1.SGM 24NON1 Federal Register / Vol. 73, No. 227 / Monday, November 24, 2008 / Notices sroberts on PROD1PC70 with NOTICES physical and mental health and performance. 3. Stimulate and support research to further understanding of the biochemical and cellular effects of dietary supplements on biological systems and their physiological impact across the life cycle. 4. Promote and support the development and improvement of methodologies appropriate to the scientific study of dietary supplement ingredients. 5. Expand and conduct outreach efforts that inform and educate the public, health care providers, and scientists about the benefits and risks of dietary supplements. ODS is re-examining its Strategic Plan and desires public comment on the progress of its programs and on future needs and opportunities for program activities. A background paper, A Report to the Public, has been prepared that summarizes progress in four key areas of ODS activities. ODS solicits comments on and suggestions for its future activities. The background paper and related information are available on the ODS Web site at http:// ods.od.nih.gov/strategicplan. Guidance is being requested from all interested parties on these important issues. • Are the current strategic goals adequate? • Is ODS meeting its stakeholders’ needs? • In the future, should some of ODS’s current programs or activities be given higher (or lower) priority? • How can ODS more effectively provide useful information to the ODS user community, including consumers, investigators, practitioners, industry, media, policy makers, government, and other interested parties? Public Participation ODS will hold a series of four Webinars at the times and topics listed below to hear comments on and suggestions for ODS initiatives for possible inclusion in the 2010–2014 ODS Strategic Plan. The topic is taken from the four areas described in the background paper, A Report to the Public. Each Webinar will begin with brief comments by a Federal partner and a stakeholder on the topic of that Webinar. The remainder of each Webinar will be devoted to hearing public comments. Research Support—Thursday, January 29, 2009, 1–2 p.m. EST. Research support is through cofunding of NIH grants, including botanical research centers, individual research grants, training, and conferences. VerDate Aug<31>2005 19:32 Nov 21, 2008 Jkt 217001 Research Tools—Tuesday, February 3, 2009, 2–3 p.m. EST. Research tools refers to the promotion and support for the development and improvement of methodologies appropriate to the scientific study of dietary supplement ingredients, including analytic methodologies and reference materials, surveys of dietary supplement use, databases to analyze survey results, and evidence-based reviews of key dietary supplements. Science-Policy—Wednesday, February 11, 2009, 1–2 p.m. EST. Science-policy covers current ODS collaborations to collect information on scientific issues that is needed for policy discussions. Three current collaborations include the vitamin D initiative, the use of dietary supplements by military personnel, and nutrient reference intake values. Communications—Thursday, February 19, 2009, 2–3 p.m. EST. Communications includes outreach and education on dietary supplements through the ODS Web site and information developed by fact sheets, newsletters, and through databases on scientific literature and research on dietary supplements. The Webinars are open to the public with attendance limited by individual access to the Internet and a phone and by the availability of open teleconference phone lines. Members of the public who wish to make an oral comment should indicate this when registering for the meeting. Instructions for registering can be found on the ODS Web site: http://ods.od.nih.gov/ strategicplan. Oral comments will be limited to three minutes and may be accompanied by a PowerPoint presentation provided that the presentation is submitted no later than 2 days before the scheduled Webinar. Individuals who register to speak will be assigned in the order in which they registered. Due to time constraints, only one representative from each organization will be allotted time for oral presentation. If time permits, those who wish to make a brief oral statement and have not preregistered to make a comment, will be able to do so. Archives of the Webinars will be posted on the ODS Web site and may be viewed at any time. We encourage individuals unable to participate in a live Webinar and all interested parties to send written comments by mail, fax, or electronically (see CONTACT INFORMATION, above.) When mailing or faxing written comments, please provide, if possible, an electronic version via e-mail. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 71017 Dated: November 10, 2008. Paul M. Coates, Director, Office of Dietary Supplements, Office of the Director, National Institutes of Health. [FR Doc. E8–27791 Filed 11–21–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: GPRA Client Outcomes for the Substance Abuse and Mental Health Services Administration (SAMHSA)—(OMB No. 0930–0208)— Revision SAMHSA’s Center for Substance Abuse Treatment (CSAT) is responsible for collecting data from discretionary services grants and contracts where client outcomes are to be assessed at three points (intake, discharge, and post-intake). SAMHSA’s CSAT-funded projects are required to submit these data as a contingency of their award. The analysis of the data also will help determine whether the goal of reducing health and social costs of drug use to the public is being achieved. The primary purpose of this data collection activity is to meet the E:\FR\FM\24NON1.SGM 24NON1

Agencies

[Federal Register Volume 73, Number 227 (Monday, November 24, 2008)]
[Notices]
[Pages 71016-71017]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27791]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Dietary Supplements 2010-2014 Strategic Plan

ACTION: Notice of Opportunity for Public Comment and Public Meetings.

-----------------------------------------------------------------------

SUMMARY: The Office of Dietary Supplements (ODS) at the National 
Institutes of Health (NIH) has initiated a strategic planning process 
that will culminate in the ODS Strategic Plan for 2010-2014. To assist 
with this process, the ODS requests input from research communities--
academic, government, and industry--and from other interested parties. 
The overall purpose of the strategic planning effort is to identify 
both new opportunities and emerging needs for incorporation in the 
programmatic efforts of the Office. A background paper has been 
prepared, A Report to the Public, that summarizes progress in four key 
areas of ODS activity. The background paper and related information are 
available on the ODS Web site at http://ods.od.nih.gov/strategicplan.
    Public comment can be sent directly to ODS or through the public 
Webinars ODS will hold on January 29, 2009, February 3, 2009, February 
11, 2009, and February 19, 2009. The section on Public Participation 
(below) gives details for the Webinars.

DATES: In order to ensure full consideration, all responses must be 
submitted by midnight, March 31, 2009.

ADDRESSES: Interested individuals and organizations should submit their 
responses to ODSplan@od.nih.gov.

FOR FURTHER INFORMATION CONTACT: Julia B. Freeman, Ph.D., Office of 
Dietary Supplements, National Institutes of Health, 6100 Executive 
Boulevard, Room 3B01, Bethesda, MD 20892-7517, Phone: 301-496-0187, 
Fax: 301-480-1845, E-mail: ODSplan@od.nih.gov.

SUPPLEMENTARY INFORMATION:

Background

    The mission of the Office of Dietary Supplements (ODS) is to 
strengthen knowledge and understanding of dietary supplements by 
evaluating scientific information, stimulating and supporting research, 
disseminating research results, and educating the public to foster an 
enhanced quality of life and health for the U.S. population. The ODS 
was established in the Office of the Director, NIH, in 1995 as a major 
provision of the Dietary Supplement Health and Education Act of 1994 
(DSHEA). A key early activity was the development of the Strategic Plan 
for 1998-2003 to set out goals for program development. The Strategic 
Plan was prepared with considerable input from NIH Institutes and 
Centers, other Federal Agencies, consumers, and other interested 
parties. The original five-year plan was revised for 2004-2009.
    The five strategic goals for ODS have been:
    1. Expand the evaluation of the role of dietary supplements in 
disease prevention and in reduction of risk factors associated with 
disease.
    2. Foster research that evaluates the role of dietary supplements 
in maintaining and improving optimal

[[Page 71017]]

physical and mental health and performance.
    3. Stimulate and support research to further understanding of the 
biochemical and cellular effects of dietary supplements on biological 
systems and their physiological impact across the life cycle.
    4. Promote and support the development and improvement of 
methodologies appropriate to the scientific study of dietary supplement 
ingredients.
    5. Expand and conduct outreach efforts that inform and educate the 
public, health care providers, and scientists about the benefits and 
risks of dietary supplements.
    ODS is re-examining its Strategic Plan and desires public comment 
on the progress of its programs and on future needs and opportunities 
for program activities. A background paper, A Report to the Public, has 
been prepared that summarizes progress in four key areas of ODS 
activities. ODS solicits comments on and suggestions for its future 
activities. The background paper and related information are available 
on the ODS Web site at http://ods.od.nih.gov/strategicplan. Guidance is 
being requested from all interested parties on these important issues.
     Are the current strategic goals adequate?
     Is ODS meeting its stakeholders' needs?
     In the future, should some of ODS's current programs or 
activities be given higher (or lower) priority?
     How can ODS more effectively provide useful information to 
the ODS user community, including consumers, investigators, 
practitioners, industry, media, policy makers, government, and other 
interested parties?

Public Participation

    ODS will hold a series of four Webinars at the times and topics 
listed below to hear comments on and suggestions for ODS initiatives 
for possible inclusion in the 2010-2014 ODS Strategic Plan. The topic 
is taken from the four areas described in the background paper, A 
Report to the Public. Each Webinar will begin with brief comments by a 
Federal partner and a stakeholder on the topic of that Webinar. The 
remainder of each Webinar will be devoted to hearing public comments.
    Research Support--Thursday, January 29, 2009, 1-2 p.m. EST.
    Research support is through cofunding of NIH grants, including 
botanical research centers, individual research grants, training, and 
conferences.
    Research Tools--Tuesday, February 3, 2009, 2-3 p.m. EST.
    Research tools refers to the promotion and support for the 
development and improvement of methodologies appropriate to the 
scientific study of dietary supplement ingredients, including analytic 
methodologies and reference materials, surveys of dietary supplement 
use, databases to analyze survey results, and evidence-based reviews of 
key dietary supplements.
    Science-Policy--Wednesday, February 11, 2009, 1-2 p.m. EST.
    Science-policy covers current ODS collaborations to collect 
information on scientific issues that is needed for policy discussions. 
Three current collaborations include the vitamin D initiative, the use 
of dietary supplements by military personnel, and nutrient reference 
intake values.
    Communications--Thursday, February 19, 2009, 2-3 p.m. EST.
    Communications includes outreach and education on dietary 
supplements through the ODS Web site and information developed by fact 
sheets, newsletters, and through databases on scientific literature and 
research on dietary supplements.
    The Webinars are open to the public with attendance limited by 
individual access to the Internet and a phone and by the availability 
of open teleconference phone lines. Members of the public who wish to 
make an oral comment should indicate this when registering for the 
meeting. Instructions for registering can be found on the ODS Web site: 
http://ods.od.nih.gov/strategicplan.
    Oral comments will be limited to three minutes and may be 
accompanied by a PowerPoint presentation provided that the presentation 
is submitted no later than 2 days before the scheduled Webinar. 
Individuals who register to speak will be assigned in the order in 
which they registered. Due to time constraints, only one representative 
from each organization will be allotted time for oral presentation. If 
time permits, those who wish to make a brief oral statement and have 
not pre-registered to make a comment, will be able to do so.
    Archives of the Webinars will be posted on the ODS Web site and may 
be viewed at any time. We encourage individuals unable to participate 
in a live Webinar and all interested parties to send written comments 
by mail, fax, or electronically (see CONTACT INFORMATION, above.) When 
mailing or faxing written comments, please provide, if possible, an 
electronic version via e-mail.

    Dated: November 10, 2008.
Paul M. Coates,
Director, Office of Dietary Supplements, Office of the Director, 
National Institutes of Health.
 [FR Doc. E8-27791 Filed 11-21-08; 8:45 am]
BILLING CODE 4140-01-P